Transmission of HIV: Study spotlights virus that starts infection
(Medical Xpress) -- When HIV is transmitted from one person to another, the virus faces a genetic "bottleneck." This means that usually during heterosexual transmission, only one virus out of a swarm of frequently mutating viruses establishes the new infection.
Now Emory Vaccine Center researchers have shown that the virus that starts an individuals new infection differs markedly from the dominant strains in his or her partners genital tract. This suggests that the process of transmission favors some viral variants, and the bottleneck effect doesnt arise simply by chance or through what types of virus flourish better in the genital tract.
The results are published online this week in Proceedings of the National Academy of Sciences, Early Edition.
If the success of the establishing virus came only by chance, most of the time it would be one of the viruses that is most abundant in the donors genital tract. But we dont see that, says senior author Eric Hunter, PhD, professor of pathology and laboratory medicine at Emory University School of Medicine. What we see suggests that transmission is selecting for certain viruses. The virus establishing the infection is a single variant, but that variant is different for each transmission event.
The first author of the paper is senior scientist Debrah Boeras, PhD, now at the Centers for Disease Control and Prevention. Dr. Hunter is co-director of Emorys Center for AIDS Research and a Georgia Research Alliance Eminent Scholar. Emory co-authors include Susan Allen, MD, MPH, professor of pathology and laboratory medicine and Cynthia Derdeyn, PhD, associate professor of pathology and laboratory medicine in Emory School of Medicine. Collaborators from Los Alamos National Laboratory contributed to the paper.
Access to patient samples came through collaboration with co-investigators and volunteers at Emorys HIV research programs in Rwanda and Zambia. The researchers obtained vaginal swabs, semen, and blood samples from eight consenting heterosexual couples in Rwanda and Zambia at the time the newly infected partners were diagnosed as HIV-positive. Of the eight instances of infection, six involved female-to-male transmission.
Boeras and her colleagues determined the DNA sequences for the viruses env gene, which encodes a protein forming the outer coat of the virus. They found that a single genetic variant in the genital tracts of the donor established an infection in the recipient.
Hunter emphasized that the papers results are the starting point for a detailed study of the distinguishing features of viruses that initiate infection.
There is clearly a lot of work still to do, he says. The big challenge now is to understand the features of the viruses that start an infection, and target them with microbicides or vaccines. It could help us be much smarter in how we try to protect people.
Other studies have already shown that founder viruses have Env proteins that are more compact and have fewer sites that can be modified with sugars, which may affect how these viruses interact with genital tissue in the uninfected partner.
This topic is the focus of current research in the Hunter laboratory, and their results could inform design of a still-elusive HIV vaccine.
More information: D.I. Boeras et al. Role of donor genital tract HIV-1 diversity in the transmission bottleneck. PNAS Early Edition (2011)
Provided by Emory University
- HIV uses several strategies to escape immune pressure Sep 19, 2009 | not rated yet | 0
- New hope for hep C vaccine Sep 13, 2011 | not rated yet | 0
- Amount of AIDS virus in genital secretions predicts risk of heterosexual transmission Apr 06, 2011 | not rated yet | 0
- Control of herpes symptoms does not reduce HIV transmission, international study found Jan 25, 2010 | not rated yet | 0
- AIDS virus changes in semen make it different than in blood Aug 19, 2010 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's ...
HIV & AIDS 7 hours ago | not rated yet | 0
(AP)—The decade-old law that transformed the battle against HIV and AIDS in developing countries is at a crossroads. The dream of future generations freed from the epidemic is running up against an era ...
HIV & AIDS 20 hours ago | not rated yet | 0
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
HIV & AIDS May 19, 2013 | 5 / 5 (1) | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
HIV & AIDS May 18, 2013 | 5 / 5 (2) | 0
Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the ...
HIV & AIDS May 17, 2013 | not rated yet | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
13 hours ago | 4.2 / 5 (5) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
11 hours ago | 4.9 / 5 (9) | 0 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
6 hours ago | 3 / 5 (2) | 0
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
7 hours ago | 5 / 5 (3) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
13 hours ago | 4.5 / 5 (6) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
8 hours ago | 5 / 5 (1) | 0 |